Infant Bacterial Therapeutics AB publ announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced operating loss was SEK 11.007 million compared to SEK 7.683 million a year ago. Net loss was SEK 10.538 million compared to SEK 7.985 million a year ago. For the nine months, operating loss was SEK 19.774 million compared to SEK 15.541 million a year ago. Net loss was SEK 18.786 million compared to SEK 16.464 million a year ago.